federal_register: 04-7533
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-7533 | Guidance for Industry on Changes to an Approved NDA or ANDA; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a revised guidance for industry entitled "Changes to an Approved NDA or ANDA." The guidance has been revised to conform to the final rule amending the agency's regulations on changes to an approved NDA or ANDA published elsewhere in this issue of the Federal Register. The guidance is intended to assist applicants in determining how they should report changes to an approved new drug application (NDA) or an abbreviated new drug application (ANDA). | 2004-04-08 | 2004 | 4 | https://www.federalregister.gov/documents/2004/04/08/04-7533/guidance-for-industry-on-changes-to-an-approved-nda-or-anda-availability | https://www.govinfo.gov/content/pkg/FR-2004-04-08/pdf/04-7533.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a revised guidance for industry entitled "Changes to an Approved NDA or ANDA." The guidance has been revised to conform to the final rule amending the agency's regulations on... |